Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences. by Touloumi, G, Pantazis, N, Antoniou, A, Stirnadel, H, Walker, SA, Porter, K

Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort. by Fidler, S, Fox, J, Touloumi, G, Pantazis, N, Porter, K, Babiker, A, Weber, J

Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice. by Touloumi, G, Pantazis, N, Stirnadel, H, Walker, A, Boufassa, F, Vanhems, P, Porter, K

Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates. by Touloumi, G, Pantazis, N, Babiker, A, Walker, SA, Katsarou, O, Karafoulidou, A, Hatzakis, A, Porter, K

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion by Stirrup, O, Copas, A, Phillips, A, Gill, M, Geskus, R, Touloumi, G, Young, J, Bucher, H, Babiker, A

Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort by Van Santen, D, Van Der Helm, J, Touloumi, G, Pantazis, N, Muga, R, Gunsenheimer-Bartmeyer, B, Gill, M, Sanders, E, Kelleher, A, Zangerle, R, Porter, K, Prins, M, Geskus, R, Cascade Collaboration Within Eurocoord

A randomized trial comparing concise and standard consent forms in the START trial by Grady, C, Touloumi, G, Walker, A, Smolskis, M, Sharma, S, Babiker, A, Pantazis, N, Tavel, J, Florence, E, Sanchez, A, Hudson, F, Papadopoulos, A, Emanuel, E, Clewett, M, Munroe, D, Denning, E, START Informed Consent Substudy Group

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. by Babiker, A, Darbyshire, J, Pezzotti, P, Porter, K, Rezza, G, Walker, SA, Beral, V, Coutinho, R, Del Amo, J, Gill, N, Lee, C, Meyer, L, Tyrer, F, Dabis, F, Thiebaut, R, Lawson-Aye, S, Boufassa, F, Hamouda, O, Fischer, K, Pezzotti, P, Rezza, G, Touloumi, G, Hatzakis, A, Karafoulidou, A, Katsarou, O

Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era by Beral, V, Coutinho, R, Darbyshire, J, Del Amo, J, Gill, N, Lee, C, Meyer, L, Rezza, G, Porter, K, Babiker, A, Walker, A, Darbyshire, J, Tyrer, F, Dabis, F, Thiebaut, R, Chene, G, Lawson-Ayayi, S, Meyer, L, Boufassa, F, Vanhems, P, Hamouda, O, Fischer, K, Pezzotti, P, Rezza, G, Touloumi, G